Home/Filings/4/0000950170-24-112941
4//SEC Filing

Angermayer Christian 4

Accession 0000950170-24-112941

CIK 0001840904other

Filed

Oct 3, 8:00 PM ET

Accepted

Oct 4, 4:32 PM ET

Size

7.5 KB

Accession

0000950170-24-112941

Insider Transaction Report

Form 4
Period: 2024-10-04
Angermayer Christian
Director10% Owner
Transactions
  • Disposition to Issuer

    Stock Option

    2024-10-04624,0000 total
    Exercise: $5.68Exp: 2025-08-20Common Shares (624,000 underlying)
  • Award

    Stock Option

    2024-10-04+624,000624,000 total
    Exercise: $5.68Exp: 2030-08-20Common Shares (624,000 underlying)
Footnotes (2)
  • [F1]No new stock options have been awarded. The transactions reported herein reflect the extension of the expiration date of certain pre-IPO stock options to align them with options granted under the Issuer's 2021 Incentive Award Plan, which is consistent with prevailing market practices.
  • [F2]The stock option is fully vested and currently exercisable.

Documents

1 file

Issuer

ATAI Life Sciences N.V.

CIK 0001840904

Entity typeother

Related Parties

1
  • filerCIK 0001845872

Filing Metadata

Form type
4
Filed
Oct 3, 8:00 PM ET
Accepted
Oct 4, 4:32 PM ET
Size
7.5 KB